Pendiri Lembaga Eijkman Prof. Herawati Sudoyo: Sains Tak Mengenal Batas | Endgame #16

TL;DR

Prof. Hera Sudoyo discusses science's limitless potential and its impact on Indonesia.

Transcript

We insert one DNA fragment to another creature into one vector or anything that later will be able to regenerate themselves. Creating something different. The next question has always been “Are we playing God?” [Voiceover: This is Endgame] - Hello friends, today we are having Professor Hera Sudoyo, an expert in molecular biology and one of the foun... Read More

Key Insights

• Prof. Herawati Sudoyo emphasizes the limitless nature of science, advocating for its universal application and the importance of scientific communication to bridge the gap with the public.
• Her journey from a small town in Indonesia to becoming a renowned molecular biologist highlights the importance of adaptability and continuous learning in scientific careers.
• The establishment of the Eijkman Institute was a strategic move to advance Indonesia's biotechnology sector, emphasizing the need for foundational research to support medical biotechnology.
• The discussion touches on the ethical considerations of genome editing and synthetic biology, highlighting the potential for both positive therapeutic applications and ethical dilemmas.
• Prof. Sudoyo underscores the importance of genomics in understanding Indonesia's diverse population, which can lead to personalized medicine and preventive healthcare strategies.
• The conversation reflects on the challenges and opportunities presented by the COVID-19 pandemic, emphasizing the need for scientific collaboration and rapid information dissemination.
• Indonesia's genetic diversity is explored, with insights into the country's complex migration history and its implications for genetic research and national identity.
• The future of science in Indonesia is envisioned as one driven by omics technologies, with a call for a supportive ecosystem to nurture scientific talent and innovation.

Questions & Answers

Q: What inspired Prof. Herawati Sudoyo to pursue a career in science?

Prof. Herawati Sudoyo was inspired by her early interest in reading and learning, which she developed during her childhood. Despite initially wanting to study architecture, she pursued a medical degree due to administrative challenges and family influence. Her passion for continuous learning and adaptability led her to molecular biology, where she has made significant contributions.

Q: How did the Eijkman Institute come to be established?

The Eijkman Institute was established to advance Indonesia's biotechnology sector, with the support of the Indonesian government and international collaboration. It was named after Christian Eijkman, a Nobel laureate, to leverage his legacy and the historical significance of the building. The institute focuses on foundational research to support medical biotechnology and national priorities.

Q: What are the ethical considerations of genome editing discussed in the interview?

The interview highlights the ethical considerations of genome editing, emphasizing the potential for both positive therapeutic applications and ethical dilemmas. Prof. Sudoyo stresses the importance of adhering to ethical guidelines to prevent misuse and the consequences of altering genetic material that could affect future generations.

Q: How does Prof. Sudoyo view the role of genomics in understanding Indonesia's population?

Prof. Sudoyo views genomics as crucial for understanding Indonesia's diverse population, which can lead to personalized medicine and preventive healthcare strategies. By studying genetic variations among different ethnic groups, scientists can develop targeted treatments and gain insights into the country's complex migration history.

Q: What challenges and opportunities does the COVID-19 pandemic present for scientists?

The COVID-19 pandemic presents both challenges and opportunities for scientists. It has accelerated the need for rapid information dissemination and collaboration, highlighting the importance of scientific communication. Scientists must adapt to new ways of working and ensure that accurate information reaches the public to combat misinformation.

Q: How does Indonesia's genetic diversity impact its national identity and scientific research?

Indonesia's genetic diversity, shaped by multiple migrations, impacts its national identity and scientific research. This diversity provides a rich resource for studying genetic variations, which can inform personalized medicine and public health strategies. Understanding this diversity also helps in defining what it means to be Indonesian in a scientific context.

Q: What is the future vision for science in Indonesia according to Prof. Sudoyo?

Prof. Sudoyo envisions a future where science in Indonesia is driven by omics technologies, with a focus on precision medicine and personalized healthcare. She calls for a supportive ecosystem that nurtures scientific talent and innovation, allowing Indonesia to compete globally and address its unique healthcare challenges.

Q: How does Prof. Sudoyo propose Indonesia should approach scientific research and innovation?

Prof. Sudoyo proposes that Indonesia should focus on building a supportive ecosystem for scientific research and innovation. This includes fostering collaboration, securing diverse funding sources, and ensuring that scientific endeavors are not hindered by short-term political cycles. She emphasizes the need for long-term thinking and the importance of creating an environment conducive to scientific discovery.

Summary & Key Takeaways

• Prof. Herawati Sudoyo discusses her journey from a small Indonesian town to becoming a leading molecular biologist, emphasizing the importance of adaptability and continuous learning in science.

• The establishment of the Eijkman Institute was crucial for advancing Indonesia's biotechnology sector, focusing on foundational research to support medical biotechnology and address national priorities.

• The conversation explores ethical considerations in genome editing and synthetic biology, highlighting both therapeutic potentials and moral dilemmas, while emphasizing the need for a supportive scientific ecosystem.